News

Pharma-Sponsored Comparison Studies Hold Clinical Value


 

EXPERT ANALYSIS FROM THE COASTAL DERMATOLOGY SYMPOSIUM

Methotrexate Vs. Azathioprine for Atopy

In the treatment of severe atopic dermatitis, methotrexate and azathioprine were found to be almost equal in efficacy (42% vs. 39%, respectively). Patients (52 completed the study) were randomized to receive 10-22.5 mg of methotrexate per week or 1.5-2.2 mg/kg per day for 12 weeks (J. Allergy Clin. Immunol. 2011;128:353-9). Outcome was assessed by blinded reviewers.

"I think that the adverse event profile of methotrexate in most people is much better, so I tend to disagree with the outcome of this study," said Dr. Fowler.

Dr. Fowler reported financial conflicts of interest with multiple pharmaceutical companies, including many of the products mentioned during his presentation.



Pages

Recommended Reading

TNF Blockers Raise Atypical Mycobacteria Infection Risk
Psoriasis Collection
TNF Antagonists in Rheumatic Patients Linked to Increased Hospitalization for Varicella Zoster
Psoriasis Collection
Get Perspective on Serious Infections With Biologic Therapies
Psoriasis Collection
Infection Odds Higher With Some Anti-TNF Agents
Psoriasis Collection
Biologics Don't Increase Herpes Zoster Risk
Psoriasis Collection
HPV Vaccine Does Not Induce Lupus Flares
Psoriasis Collection
FDA: TNF Blockers Up Risk of Legionella, Listeria Infection
Psoriasis Collection
Psoriasis in the Patient With Human Immunodeficiency Virus, Part 1: Review of Pathogenesis
Psoriasis Collection
Psoriasis in the Patient With Human Immunodeficiency Virus, Part 2: Review of Treatment
Psoriasis Collection
Cutaneous Manifestations of Diabetes Mellitus: A Case Series
Psoriasis Collection